Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tau PET Imaging with [18F]PM-PBB3 in Frontotemporal Dementia with MAPT Mutation.

Journal of Alzheimer's disease : JAD - 1 Jan 2020

Su Ya, Fu Jiayu, Yu Jintai, Zhao Qianhua, Guan Yihui, Zuo Chuantao, Li Ming, Tan Haibo, Cheng Xin

Abstract excerpt

BACKGROUND: Flortaucipir (AV-1451) and pyridinyl-butadienyl-benzothiazole 3 (PBB3) are newly developed and commonly used positron emission tomography (PET) tracers to detect tau deposition in tauopathies, including frontotemporal dementia (FTD). [18F]PM-PBB3, as a second-generation compound, has not been described in FTD so far. OBJECTIVE: We aim to explore the in vivo performance of [18F]PM-PBB3 tau PET in an...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Benzothiazoles
Share to Carbon Radioisotopes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Contrast Media

Share to Fluorodeoxyglucose F18

Share to Frontotemporal Dementia

Share to Magnetic Resonance Imaging

Share to Positron-Emission Tomography

Share to tau Proteins

Source

Identifiers

PMID: 32444551
DOI: 10.3233/JAD-200287

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tau PET Imaging with [18F]PM-PBB3 in Frontotemporal Dementia with MAPT Mutation.PMID 32444551Read ↗

18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers.Semantic proximity Read ↗

A Peculiar Tau Accumulation Pattern Identified Via 18 F-Florzolotau PET Imaging in a Patient With Frontotemporal Dementia Caused by a Mutation in the MAPT Gene.Semantic proximity Read ↗

[18F]Flortaucipir PET Across Various MAPT Mutations in Presymptomatic and Symptomatic Carriers.Semantic proximity Read ↗

Frontotemporal dementia with the V337M MAPT mutation: Tau-PET and pathology correlations.Semantic proximity Read ↗

High-contrast in-vivo imaging of tau pathologies in Alzheimer’s and non-Alzheimer’s disease tauopathiesSemantic proximity Read ↗

[18F]AV‐1451 PET in behavioral variant frontotemporal dementia due to MAPT mutationSemantic proximity Read ↗

In vivo 18F-AV-1451 tau PET signal in MAPT mutation carriers varies by expected tau isoforms.Semantic proximity Read ↗

In vivo PET classification of tau pathologies in patients with frontotemporal dementiaSemantic proximity Read ↗

Invited review: Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging.Semantic proximity Read ↗

18F-MK-6240 tau-PET in genetic frontotemporal dementia.Semantic proximity Read ↗

Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls.Semantic proximity Read ↗

In Vivo 18 F-APN-1607 Tau Positron Emission Tomography Imaging in MAPT Mutations: Cross-Sectional and Longitudinal Findings.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.